SEC Filing - Marker Therapeutics, Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Laskow-Pooley David

(Last)

(First)

(Middle)

50 NORTH LAURA STREET, SUITE 2500

(Street)

JACKSONVILLE

32202

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2015

3. Issuer Name and Ticker or Trading Symbol
TAPIMMUNE INC [ TPIV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

Remarks:

* Mr. Mark A. Catchur is signing as Attorney-in-Fact pursuant to power of attorney dated November 4, 2015 granted by each Reporting Person, a copy of which is filed as an exhibit and incorporated herein by reference.

No securities are beneficially owned.

	/s/ Mark A. Catchur as Attorney-In-Fact for David Laskow-Pooley*	11/13/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

                    POWER OF ATTORNEY FOR SECTION 16 FILINGS

       The undersigned, David Laskow-Pooley, an individual, (the "Undersigned")
does hereby make, constitute and appoint Mark A. Catchur, Paul Lynch, April
Richards-Parker, Edward Richardson, Glynn Wilson, Judy Jaggie and Elizabeth
Donnelley, and each of them acting individually, his true and lawful attorneys
for the purposes hereinafter set forth, effective as of this 4th day of
November, 2015.

       References in this power of attorney to "attorney-in-fact" are to each
of the persons named above and to the person or persons substituted hereunder
pursuant to the power of substitution granted herein.

       The Undersigned hereby grants to the Attorney-in-Fact, for the
Undersigned and in his name, place and stead the power:

(1)    prepare and submit to the U.S. Securities and Exchange Commission (the
       "SEC") a Form ID, including amendments thereto, and any other documents
       necessary or appropriate to obtain codes, passwords, and passphrases
       enabling the undersigned to make electronic filings with the SEC of
       reports required by Section 16(a) of the Securities Exchange Act of 1934
       or any rule or regulation of the SEC;

(2)    execute for and on behalf of the undersigned, in the undersigned's
       capacity as an officer and/or director of TapImmune, Inc. (the
       "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
       Securities Exchange Act of 1934 and the rules thereunder;

(3)    do and perform any and all acts for and on behalf of the undersigned
       which may be necessary or desirable to complete and execute any such Form
       3, 4, or 5, complete and execute any amendment or amendments thereto, and
       file such form with the United States Securities and Exchange Commission
       and any stock exchange or similar authority; and

(4)    take any other action of any type whatsoever in connection with the
       foregoing which, in the opinion of such attorney-in-fact, may be of
       benefit to, in the best interest of, or legally required by, the
       undersigned, it being understood that the documents executed by such
       attorney-in-fact on behalf of the undersigned pursuant to this Power of
       Attorney shall be in such form and shall contain such terms and
       conditions as such attorney-in-fact may approve in such attorney-in-
       fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.   The Undersigned shall
indemnify and hold harmless each attorney-in-fact for any exercise of the powers
granted hereby.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

This Power of Attorney may be executed and delivered by facsimile, PDF or
other electronic transmission and shall be deemed to have the same legal effect
as delivery of an original signed copy of this Power of Attorney.


       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed on the date first written above.


      By:   /s/David Laskow-Pooley
            ----------------------
      Name:    David Laskow-Pooley